dexamethasone,daratumumab,lenalidomide
janssen
['mmsm']
great study by ifm- dara/len vs len/dex frail pts with #mmsm dara/len with responses, but jury still out on safer? discontinuation rates due to ae's (~15%) similar in both arms, more hematological toxicity with dara/len. wish there was a qol analysis! #ash22 
Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.